Gene study aims to make Post-Surgery painkillers safer
NCT ID NCT06996561
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a person's genetic makeup influences how well the painkiller nalbuphine works after abdominal or pelvic surgery. Researchers will collect blood samples from 263 adults before and after surgery to analyze genes linked to pain relief. The goal is to improve pain management and reduce the risk of opioid-related problems in the Pakistani population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APPENDECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ziauddin University
RECRUITINGKarachi, Sindh, 755000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can patients safely dispense their own pain medicine after surgery?
- A simple pressure test before surgery might reveal your risk of chronic pain
- Can a VR headset calm nerves before surgery?
- Can a ketamine boost during surgery slash opioid needs?
- Can a less invasive nerve block match the gold standard for chest surgery pain?
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?